Created by Dr. Jan-Frederik Mai

Static pricing-hedging duality for credit default swaps and the negative basis arbitrage

Assuming the absence of arbitrage in a single-name credit risk model, it is shown how to replicate the risk-free bank account until a credit event by a static portfolio of a bond and infinitely many credit default swaps (CDS). From the viewpoint of classical arbitrage pricing theory this static portfolio can be viewed as the solution of a credit risk hedging problem whose dual problem is to price the bond consistently with the CDS. This duality is maintained when the risk-free rate is shifted parallelly. In practice, there is a unique parallel shift that is consistent with observed market prices for bond and credit default swaps. The resulting, risk-free trading strategy in case of a positive shift earns more than the risk-free rate, is referred to as negative basis arbitrage in the market, and the parallel shift defined in this way is a scientifically well-justified definition for what the market calls negative basis. In economic terms, it is a premium for taking the un-modeled residual risks of a bond investment after interest rate risk and credit risk are hedged away, predominantly these are liquidity risk and legal risk.



Terms & Conditions
Please carefully read our Legal Notices and our Privacy Policy.

In this context, we must draw your particular attention to the following legal conditions:

Neither the information nor the opinions made available on this Website constitute an invitation, offer or recommendation to purchase, sell or otherwise dispose of a financial instruments, nor to make another transaction or to provide investment advice or any other service. Any investment decision relating to one of the products described herein must only be based on the respective sales documents (e.g. sales prospectus, semi-annual or annual reports, key investor information documents etc.).
The products referred to on this website may not be offered in all jurisdictions and may only be purchased by those investors entitled to do so. The information and contents of this website are not addressed to any persons or legal entities whose domicile prohibits the distribution of this information. All persons and legal entities whose domiciles are subject to a foreign jurisdiction should inform themselves about and observe these restrictions.

The information on this website is not addressed to the USA. US nationals, legal entities and persons with residence in the USA may not access this website. The information on this website may not be distributed or passed on in the USA. Xaia products referred to on this website will not be registered under the United States Securities Act of 1933 and no approval has been obtained in compliance with the US Commodities Exchange Act of 1936. Xaia products listed on this website may not be offered or sold in the USA either to citizens, or to US residents, or to legal entities domiciled in the USA.

The disclaimer confirmation of visitors to this website is stored as a necessary cookie on your device, is valid for a period of 90 days, however this can be reset at anytime by deleting your browser’s cookies.  For further information, please see our Privacy Policy.

Please provide your origin.
Please tell us whether you are an institutional or a private investor.
You have to agree, in order to use our online presence.